Normal tension glaucoma (NTG) is a form of glaucoma where the optic nerve suffers progressive damage even though eye pressure stays within the normal range, below 21 mmHg. In most types of glaucoma, elevated pressure inside the eye is the clear culprit. In NTG, pressure readings look fine on paper, which makes the condition harder to catch and has led researchers to look beyond pressure alone for explanations.
How It Differs From Other Glaucoma
All forms of open-angle glaucoma share certain features: thinning of the nerve fiber layer at the back of the eye, characteristic blind spots on visual field testing, and a drainage angle that appears physically open. The defining feature of NTG is that intraocular pressure (IOP) remains consistently below 21 mmHg, the threshold traditionally considered normal. Most people with NTG have pressures in the higher teens, though some register in the low teens.
This matters because standard glaucoma screenings often rely heavily on pressure checks. A person with NTG can pass a routine pressure test and still be losing vision. That’s why eye care providers also examine the optic nerve directly, use imaging to measure nerve fiber thickness, and run visual field tests that map peripheral vision. A pressure reading alone is not enough to rule glaucoma out.
Why the Optic Nerve Gets Damaged
Because elevated pressure doesn’t explain the damage, researchers have proposed several overlapping mechanisms. The most studied is vascular dysregulation: the blood vessels supplying the optic nerve fail to maintain steady blood flow when conditions change. This creates episodes of reduced oxygen delivery, gradually injuring nerve fibers. Multiple studies have confirmed impaired blood flow to the eye in people with NTG.
Low blood pressure, particularly overnight drops, plays a significant role. When systemic blood pressure falls during sleep, the perfusion pressure that pushes blood through the optic nerve drops with it. Large swings in blood pressure throughout the day have been identified as a major risk factor for worsening visual field loss. This is one reason why aggressively treating high blood pressure in someone with NTG can sometimes backfire, driving nighttime pressures too low and starving the nerve of blood.
A third theory involves the pressure balance across the lamina cribrosa, a sieve-like structure at the back of the eye where nerve fibers exit. Eye pressure pushes forward on this structure while cerebrospinal fluid pushes from behind. If cerebrospinal fluid pressure is unusually low, even a “normal” eye pressure creates a larger pressure difference across the lamina cribrosa, potentially deforming and damaging nerve fibers. Some NTG patients have been found to have lower than average cerebrospinal fluid pressure, supporting this idea.
It’s likely that NTG isn’t one disease with one cause. For some people, vascular insufficiency dominates. For others, the pressure gradient or an unusual sensitivity of the optic nerve itself may be the primary driver.
The Corneal Thickness Problem
Some people diagnosed with NTG may not actually have it. The standard tool for measuring eye pressure, applanation tonometry, assumes a typical corneal thickness. If your corneas are thinner than average, the device underestimates your true pressure. One study found that the average corneal thickness in NTG patients was significantly lower than in people with regular open-angle glaucoma or healthy controls. After correcting pressure readings for corneal thickness, 31% of patients originally diagnosed with NTG were reclassified as having standard high-pressure glaucoma. Their corrected average pressure jumped from about 17 mmHg to nearly 19.5 mmHg.
This doesn’t mean NTG is always a measurement artifact. It does mean that corneal thickness measurement is an important part of confirming the diagnosis.
Risk Factors and Who Gets It
NTG is notably common in East Asian populations. In Japan, for example, NTG accounts for the majority of glaucoma cases. People of African descent face higher overall glaucoma rates, though high-pressure glaucoma tends to be more common in that group. Family history of glaucoma, older age, and being female are additional risk factors.
Several systemic conditions show up more often in people with NTG. Migraines and Raynaud’s phenomenon (where fingers turn white in the cold due to blood vessel spasms) both reflect the kind of vascular instability seen in NTG. Obstructive sleep apnea is significantly more common as well. One prospective study found that about 42% of NTG patients had sleep apnea compared to 12.5% of matched controls. The repeated drops in oxygen and spikes in vascular resistance during apnea episodes are thought to compromise blood flow to the optic nerve. In that study, treating sleep apnea with a CPAP machine appeared to stabilize glaucoma damage.
Diagnostic Clues Specific to NTG
Certain findings on examination point toward NTG rather than other types of glaucoma. Disc hemorrhages, small splinter-shaped bleeds on or near the optic nerve head, are more common in NTG than in high-pressure glaucoma. In one study, disc hemorrhages appeared in 50% of NTG patients during follow-up, most frequently at the lower-outer portion of the disc. These hemorrhages are considered a warning sign that nerve damage is progressing and that new visual field loss may follow. They reinforce the idea that vascular factors are central to the disease.
Visual field defects in NTG also tend to cluster closer to the center of vision and appear deeper and more localized than the broader peripheral losses typical of high-pressure glaucoma. This pattern means that NTG can threaten reading and driving vision relatively early.
How NTG Is Treated
Lowering eye pressure remains the primary treatment, even though the pressure is already technically “normal.” The landmark Collaborative Normal Tension Glaucoma Study established that reducing IOP by 30% from baseline slowed disease progression. That target has guided treatment ever since. Pressure-lowering eye drops are usually the first step, with laser treatment or surgery reserved for cases that continue to worsen.
Because vascular factors play such a large role, managing the whole picture matters. Identifying and treating sleep apnea, avoiding excessive blood pressure lowering at night, and addressing vasospastic conditions can all help protect the optic nerve. Some research has explored whether calcium channel blockers, a class of blood pressure medication, might offer direct neuroprotection. Small studies have shown these drugs can increase blood flow to the optic nerve and may help stabilize visual field loss. Lab research supports the idea that they protect nerve cells from damage. However, a clear causal benefit hasn’t been established in large trials, and some population data have raised questions about whether certain blood pressure medications could have mixed effects on glaucoma risk.
Monitoring is especially important in NTG because the disease can progress slowly and silently. Regular visual field tests and nerve fiber imaging, typically every six to twelve months, allow your eye doctor to detect changes early and adjust treatment. Since NTG has no symptoms until significant vision is lost, consistent follow-up is what separates stable disease from preventable blindness.